NASDAQ:DRTS Alpha Tau Medical Q4 2025 Earnings Report $14.52 -0.62 (-4.10%) Closing price 09/23/2026 04:00 PM EasternExtended Trading$14.48 -0.04 (-0.30%) As of 09/23/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Alpha Tau Medical EPS ResultsActual EPS-$0.14Consensus EPS -$0.13Beat/MissMissed by -$0.01One Year Ago EPSN/AAlpha Tau Medical Revenue ResultsActual RevenueN/AExpected Revenue$0.06 millionBeat/MissN/AYoY Revenue GrowthN/AAlpha Tau Medical Announcement DetailsQuarterQ4 2025Date3/9/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsAlpha Tau Medical's Q3 2026 earnings is estimated for Thursday, November 19, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, November 17, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (6-K)Annual Report (20-F)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(6-K)Annual report(20-F) Alpha Tau Medical Earnings HeadlinesAlpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Rating of "Hold" by BrokeragesSeptember 20, 2026 | americanbankingnews.comAlpha Tau Medical consensus price target raised 23.61% to $18.16September 15, 2026 | msn.comWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent. | Stansberry Research (Ad)Alpha Tau's Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next.September 15, 2026 | markets.businessinsider.comOramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And MoreSeptember 11, 2026 | seekingalpha.comAlpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM BreakthroughSeptember 4, 2026 | seekingalpha.comSee More Alpha Tau Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Tau Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Tau Medical and other key companies, straight to your email. Email Address About Alpha Tau MedicalAlpha Tau Medical (NASDAQ:DRTS) is an Israel-based biotechnology and medical technology company developing targeted alpha radiation therapies for the treatment of solid tumors. Its lead technology, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver localized alpha radiation directly within a tumor while limiting exposure to surrounding healthy tissue. Alpha DaRT uses radium-224 sources placed into or near a tumor. As the radium decays, its short-range alpha-emitting products are intended to diffuse through the tumor and destroy cancer cells. The company has evaluated the technology in clinical studies across several cancer indications, including cutaneous squamous cell carcinoma and other solid tumors. Alpha Tau was founded in Israel and has conducted research and clinical development activities in Israel, the United States and other international locations. The company is led by Chief Executive Officer Uzi Sofer and continues to focus on advancing Alpha DaRT through clinical development and potential regulatory approval for cancer treatment.View Alpha Tau Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Energy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock?Thor Industries Is Boring—And That May Be Its Biggest AdvantageAutoZone Shifts Gears, On Track to Reverse Course and Price RecoveryMeta’s Muse Highlights Arm’s Growing Role in AI InfrastructureOld Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom Upcoming Earnings Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
